A citation-based method for searching scientific literature

R E Ratner, R Dickey, M Fineman, D G Maggs, L Shen, S A Strobel, C Weyer, O G Kolterman. Diabet Med 2004
Times Cited: 164



Steve Edelman, Satish Garg, Juan Frias, David Maggs, Yan Wang, Bei Zhang, Susan Strobel, Karen Lutz, Orville Kolterman. Diabetes Care 2006
Times Cited: 95




List of shared articles



Times cited


A systematic review and dose-response meta-analysis on the efficacy of dapagliflozin in patients with type 1 diabetes mellitus.
Ahmed Abu-Zaid, Abdulaziz Khalaf Altowairqi, Thusharika Dissanayaka, Artem Oganesyan, Akshaya Srikanth Bhagavathul, Habeeb Alhabeeb, Amirah Baradhwan, Sara Alomar, Sebastian Tom. Pharmacol Res 2021
0

Double Diabetes: A Growing Problem Requiring Solutions.
Djordje S Popovic, Nikolaos Papanas. Exp Clin Endocrinol Diabetes 2021
0

Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?
Jennifer R Snaith, Deborah J Holmes-Walker, Jerry R Greenfield. Trends Endocrinol Metab 2020
5

New Frontiers in the Treatment of Type 1 Diabetes.
Jeremy T Warshauer, Jeffrey A Bluestone, Mark S Anderson. Cell Metab 2020
16


A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Ahmad Haidar, Michael A Tsoukas, Sarah Bernier-Twardy, Jean-Francois Yale, Joanna Rutkowski, Anne Bossy, Evelyne Pytka, Anas El Fathi, Natalia Strauss, Laurent Legault. Diabetes Care 2020
25

A co-formulation of supramolecularly stabilized insulin and pramlintide enhances mealtime glucagon suppression in diabetic pigs.
Caitlin L Maikawa, Anton A A Smith, Lei Zou, Gillie A Roth, Emily C Gale, Lyndsay M Stapleton, Sam W Baker, Joseph L Mann, Anthony C Yu, Santiago Correa,[...]. Nat Biomed Eng 2020
5

Adjunct therapies in treatment of type 1 diabetes.
Itivrita Goyal, Alamgir Sattar, Megan Johnson, Paresh Dandona. J Diabetes 2020
2

Pharmacological therapies to address obesity in type 1 diabetes.
Anna Casu, Anika Bilal, Richard E Pratley. Curr Opin Endocrinol Diabetes Obes 2020
0


Adjunct Antihyperglycemic Agents in Overweight and Obese Adults With Type 1 Diabetes.
Diana Isaacs, Stephanie Yager, Marcie Parker, Lauren Wolfe, Jennifer Luxenburg, Sanela Lekic. Ann Pharmacother 2019
3




Role of Noninsulin Therapies in the Treatment of Type 1 Diabetes.
Sara E Lingow, Sandra D Burke, Amie D Brooks, Pat S Rafferty. Diabetes Spectr 2019
0

Pharmacotherapy of type 2 diabetes: An update.
Jagriti Upadhyay, Stergios A Polyzos, Nikolaos Perakakis, Bindiya Thakkar, Stavroula A Paschou, Niki Katsiki, Patricia Underwood, Kyung-Hee Park, Jochen Seufert, Eun Seok Kang,[...]. Metabolism 2018
68

Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes.
Alfonso Galderisi, Jennifer Sherr, Michelle VanName, Lori Carria, Melinda Zgorski, Eileen Tichy, Kate Weyman, Eda Cengiz, Stuart Weinzimer, William Tamborlane. J Clin Endocrinol Metab 2018
9

IAPP and type 1 diabetes: implications for immunity, metabolism and islet transplants.
Heather C Denroche, C Bruce Verchere. J Mol Endocrinol 2018
11

Adjunctive therapy for glucose control in patients with type 1 diabetes.
Kira Harris, Cassie Boland, Lisa Meade, Dawn Battise. Diabetes Metab Syndr Obes 2018
7

Non-insulin pharmacological therapies for treating type 1 diabetes.
Christian Seerup Frandsen, Thomas Fremming Dejgaard, Sten Madsbad, Jens Juul Holst. Expert Opin Pharmacother 2018
4

Adjuvant Pharmacotherapies to Insulin for the Treatment of Type 1 Diabetes.
Mustafa Tosur, Maria J Redondo, Sarah K Lyons. Curr Diab Rep 2018
4

Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward?
Harriet Warnes, Rebecca Helliwell, Sam Matthew Pearson, Ramzi A Ajjan. Diabetes Ther 2018
7

Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study.
Matthew C Riddle, Rajaa Nahra, Jenny Han, Jessica Castle, Kathryn Hanavan, Marcus Hompesch, David Huffman, Poul Strange, Peter Öhman. Diabetes Care 2018
15

Neuroprotective Effects of Amylin Analogues on Alzheimer's Disease Pathogenesis and Cognition.
John Grizzanti, Rachel Corrigan, Gemma Casadesus. J Alzheimers Dis 2018
5

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.
Jay S Skyler, George L Bakris, Ezio Bonifacio, Tamara Darsow, Robert H Eckel, Leif Groop, Per-Henrik Groop, Yehuda Handelsman, Richard A Insel, Chantal Mathieu,[...]. Diabetes 2017
157


Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis.
Yong-Chao Qiao, Wei Ling, Yan-Hong Pan, Yin-Ling Chen, Dan Zhou, Yan-Mei Huang, Xiao-Xi Zhang, Hai-Lu Zhao. Oncotarget 2017
15


Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus.
Christian Seerup Frandsen, Thomas Fremming Dejgaard, Sten Madsbad. Lancet Diabetes Endocrinol 2016
41

Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials.
Kathrin Herrmann, Steven C Brunell, Yan Li, Ming Zhou, David G Maggs. Adv Ther 2016
11

Neuroendocrine hormone amylin in diabetes.
Xiao-Xi Zhang, Yan-Hong Pan, Yan-Mei Huang, Hai-Lu Zhao. World J Diabetes 2016
20

Cardiovascular safety assessment of pramlintide in type 2 diabetes: results from a pooled analysis of five clinical trials.
Kathrin Herrmann, Ming Zhou, Andrew Wang, Tjerk W A de Bruin. Clin Diabetes Endocrinol 2016
6

Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetes.
M C Riddle, K C J Yuen, T W de Bruin, K Herrmann, J Xu, P Öhman, O G Kolterman. Diabetes Obes Metab 2015
15

Role of Amylin in Type 1 and Type 2 Diabetes.
Laura Hieronymus, Stacy Griffin. Diabetes Educ 2015
19

Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy.
Dante J Merlino, Erik S Blomain, Amanda S Aing, Scott A Waldman. J Clin Med 2014
6



Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes.
Stuart A Weinzimer, Jennifer L Sherr, Eda Cengiz, Grace Kim, Jessica L Ruiz, Lori Carria, Gayane Voskanyan, Anirban Roy, William V Tamborlane. Diabetes Care 2012
81

Pramlintide: profile of an amylin analog.
Harold E Lebovitz. Expert Rev Endocrinol Metab 2012
0

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan.
Yehuda Handelsman, Jeffrey I Mechanick, Lawrence Blonde, George Grunberger, Zachary T Bloomgarden, George A Bray, Samuel Dagogo-Jack, Jaime A Davidson, Daniel Einhorn, Om Ganda,[...]. Endocr Pract 2011
279

Pramlintide and the treatment of diabetes: a review of the data since its introduction.
Lisa M Younk, Maia Mikeladze, Stephen N Davis. Expert Opin Pharmacother 2011
47

Gut peptide hormones and pediatric type 1 diabetes mellitus.
M Huml, J Kobr, K Siala, J Varvařovská, R Pomahačová, M Karlíková, J Sýkora. Physiol Res 2011
21

Noninsulin pharmacological management of type 1 diabetes mellitus.
Vishvas Garg. Indian J Endocrinol Metab 2011
7

Novel strategy for the use of leptin for obesity therapy.
Charmaine S Tam, Virgile Lecoultre, Eric Ravussin. Expert Opin Biol Ther 2011
25

The alpha-cell as target for type 2 diabetes therapy.
Mikkel Christensen, Jonatan I Bagger, Tina Vilsbøll, Filip K Knop. Rev Diabet Stud 2011
28

The role of pramlintide for weight loss.
Kaelen C Dunican, Nicole M Adams, Alicia R Desilets. Ann Pharmacother 2010
19